§ 13F · FUND PROFILE
ACORN CAPITAL ADVISORS, LLC.
AUM · $197M (13F)Positions · 20Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$2M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED AUG 14, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | CGON | CG ONCOLOGY INC | 1.13M | $80M | 21.9% | ±0% |
| 2 | URGN | UROGEN PHARMA LTD | 1.67M | $62M | 16.8% | ±0% |
| 3 | TRVI | TREVI THERAPEUTICS INC | 2.14M | $40M | 10.9% | ±0% |
| 4 | CADL | CANDEL THERAPEUTICS INC | 3.50M | $36M | 9.8% | ±0% |
| 5 | PBYI | PUMA BIOTECHNOLOGY INC | 4.13M | $34M | 9.1% | ±0% |
| 6 | JBIO | JADE BIOSCEINCES INC | 987K | $22M | 6.0% | +25% |
| 7 | BCAX | BICARA THERAPEUTICS | 643K | $19M | 5.2% | ±0% |
| 8 | KPTI | KARYOPHARM THERAPEUTICS INC | 1.52M | $15M | 4.0% | +427% |
| 9 | OKUR | ONKURE THERAPEUTICS INC | 2.84M | $13M | 3.5% | ±0% |
| 10 | HELP | HELUS PHARMA INC. | 1.54M | $10M | 2.8% | ±0% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE ACORN SIGNAL
AC read
ACORN CAPITAL ADVISORS, LLC is a Other fund managing $197 million in assets. The fund runs a focused portfolio of just 20 positions.
Read the full dossier →